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The power curve is shown below. It shows that from a potential 270 farms included 
in the FSA survey, only 50 farms on average, equating to an average of 1645 pat 
samples, would have a sample VTEC O157 prevalence of >0% or <100% and thus 
require testing for F. hepatica. This would yield power of 87% to detect an odds 
ratio of 2, hence there is potential to test fewer farms. Repeating the exercise with 
225 farms, we find that we expect to apply F. hepatica testing to 42 farms, equating 
to approximately 269 fewer pat sample tests, whilst yielding power of 82%.  
 
A sensitivity analysis on the power to detect different effect sizes ranged from 
13.5% (for OR = 1.2) to 99.5% (for OR = 3.0). The power to detect an OR of 1.8 
would be 75%. Sensitivity analyses on changes to the farm-level prevalence of 
VTEC O157 showed that a reduction was commensurate with a reduction in 
statistical power, whereas change to the F. hepatica prevalence values had 
relatively smaller influence. 
 
 
Farms. The proposed study design should have a mean and median sample size, 
nj, of approximately 27 and 23 cows per farm respectively, with a range of 1 to 113. 
We simulate sample sizes nj – 1 from a Beta-Binomial(112, 1.32, 4.35) distribution. 
 
F. hepatica infection. Based on existing data, we want the approximate marginal 
prevalence of F. hepatica among individual cows (ignoring clustering effects) to be 
20%, and the farm-level prevalence (the proportion of farms with ≥1 cow testing 
positive for F. hepatica) to be 80% (McCann et al. 2010). To achieve this, within 
each farm we infect cows with F. hepatica, in silico, with a within-farm probability rj 
sampled from a Beta distribution with shape parameters  0.99 and 3.97. 
 
Farm effects and VTEC O157 infection. Based on existing data, we want the 
approximate marginal prevalence of VTEC O157 among individual cows to be 4%, 
and the farm-level prevalence to be 19% (Pearce et al. 2009). When β = log(2), we 
simulate farm-level random effects αj on the logit scale from a normal distribution 
with mean μ = –7.09 and standard deviation σ = 3.52. We then infect each cow i on 
farm j, in silico, with probability pij, as defined by the model above. 
 
We exploit the fact that each VTEC O157 test result will be known in advance of 
the samples being requested for F. hepatica testing. If each sample were to be 
tested at the same time for both pathogens, then >7000 F. hepatica tests would 
need to be carried out across 270 farms. As VTEC O157 has a relatively low 
prevalence, many farms will have a sample prevalence of 0%. These farms 
contribute little to the estimation of the model parameters of interest; therefore we 
exclude them prior to fitting the regression model. By similar reasoning, we 




















Left panel: a single simulation showing distribution of farm-level prevalence data. 
Right panel: distribution of average prevalence and sample size across 2500 
simulations. 
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The parasite Fasciola hepatica is a major cause of economic loss to the agricultural 
community worldwide as a result of morbidity and mortality in livestock, including 
cattle. Cattle are the principle reservoir of verocytotoxigenic Escherichia coli O157 
(VTEC O157), an important cause of disease in humans. To date there has been 
little empirical research on the interaction between F. hepatica and VTEC O157. It 
is hypothesised that F. hepatica, which is known to suppress type 1 immune 
responses and induce an anti-inflammatory or regulatory immune environment in 
the host, may promote colonisation of the bovine intestine with VTEC O157. Here 
we assess whether it is statistically feasible to augment a prospective study to 
quantify the prevalence of VTEC O157 in cattle in Great Britain with a pilot study to 
test this hypothesis. 
 
On observing the data, we will fit a mixed effects logistic regression model. In the 
absence of data on other explanatory variables, this model will be  
 
logit(pij) = αj + βxij  
where 
• pij is the probability of cow i on farm j testing positive for VTEC O157 
• αj is the intercept for farm j, such that each αj are conditionally independently 
distributed normally with mean μ and standard deviation σ 
• xij = 1 if cow i on farm j tests positive for F. hepatica, and 0 otherwise 
• β is the natural log odds ratio (OR) for a positive F. hepatica test 
 
There is no closed-form solution for the power of the test, and we therefore use a 
simulation-based approach (Gelman and Hill 2007) as follows. 
1. Simulate a plausible synthetic dataset that adheres to any known constraints 
under the alternative hypothesis. 
2. Fit the proposed regression model. 
3. Test the null hypothesis at the 5% significance level. 
4. Repeat 2500 times and calculate the power as the proportion of simulations 
where the null hypothesis was rejected.  
We simulate synthetic datasets (item 1 above) using marginal prevalence data from 
the published literature to calculate distributional parameters by exploitation of the 
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From a total of 270 farms (mean 27 cows per farm) that will be tested for 
VTEC O157, power of 87% can be achieved, whereby testing of F. hepatica would 
only be necessary for an expected 50 farms, thus considerably reducing costs. Pre-
study power calculations are an important part of any study design. The framework 
developed here might be applicable to the study of other co-infections. 
 
Our study makes a number of assumptions, including infection prevalence values 
holding constant; no spatiotemporal variation; and perfect diagnostic tests. 
Trimming the data by excluding farms with either 0% or 100% sample prevalence 
for VTEC O157 confers a substantial reduction in cost but could, in principle, 
invalidate the subsequent analysis. We recommend that users of the approach 
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